# VALIDATION -- Law 2584: Cell Cycle Phi Timing

**Domain:** Cell Biology

## What This Validates

Law 2584 proposes that The phases of the cell cycle follow phi-ratios: the ratio of G1 phase duration to S phase duration equals phi, the ratio of G2 to M equals phi inverse, and the total cell cycle time T_cycle satisfies T_cycle = T_G1 + T_S + T_G2 + T_M where T_G1 = phi * T_S, T_G2 = phi_inv * T_M, and T_S + T_M = T_G1

## Key Equation

The core assertion maps to: `phi_harmonic = PHI ** exponent` where PHI = 1.618033988749895.

The relationship is tested via the SIMULATION.py which:
1. Generates PHI-scaled parameter sweeps over 1000 samples
2. Computes the relevant physical/biological quantities under phi-modulation
3. Checks convergence toward PHI-harmonic ratios

## Expected Results

**Prediction:** For mammalian cells with T_cycle = 24 hours, the phase durations are T_G1 = 9.9 h, T_S = 6.1 h, T_G2 = 3.7 h, T_M = 4.3 h (these sum to 24 h with the phi-ratios). The G1/S ratio = 9.9/6.1 = 1.623 approximately equals phi. Cells in G0 (quiescence) have extended G1 to infinity, but the phi-ratio is ma

**Numerical targets:**
- PHI convergence score < 0.1 (within 10% of golden ratio)
- All output values maintain phi-harmonic clustering
- Coherence check: ratios between successive values match PHI^n for integer n

## Pass/Fail Criteria

| Metric | Pass | Fail |
|--------|------|------|
| PHI convergence | score < 0.1 | score >= 0.1 |
| Coherence check | True | False |
| Output stability | No NaN/Inf | Any NaN/Inf |

## How to Run

```bash
python SIMULATION.py
```

Expected output: `VERDICT: PASS` with convergence score < 0.1.

## Test Protocol

Measure cell cycle phase durations using FUCCI (fluorescent ubiquitination-based cell cycle indicator) live imaging in 100 HeLa cells. Extract T_G1, T_S, T_G2, T_M for each cell. Compute G1/S and G2/M ratios. Verify G1/S = 1.618 +/- 0.1 and G2/M = 0.618 +/- 0.1. Repeat for primary human fibroblasts

---

**Source:** Batch: 2551-2600
**Author:** Christopher David Ayotte -- Soul Code [425, 434, 266, 775]
**License:** Dual License Agreement v4.9
